AD/PD™ 2025 Junior Faculty Awards

Applicatoin is closed.

For every edition of the AD/PD™ International Conference the Organizing Committee recognizes the top junior and trainee abstract presenters with Junior Faculty Awards*.

Recipients of this award will give an oral presentation on their research during the Conference.

The application deadline for the 2025 Junior Faculty Awards was September 25, 2024.

Application is through the abstract submission system.

*Eligible candidates for the Junior Faculty Awards are graduate students (PhD, MD) or junior scientists up to five years after the doctorate degree (PhD, MD).

Meet the AD/PD™ 2025 Junior Faculty Award Winners

Kyusik Ahn

South Korea

Abstract: BYPASSING BLOOD-BRAIN BARRIER (BBB): THE ROLE OF VISCERAL SENSORY NERVES (VSN) IN THE TRANSMISSION OF PATHOGENIC MOLECULES FROM GUT TO BRAIN IN ALZHEIMER’S DISEASE (AD)

Dario Bachmann

Switzerland

Abstract: INFLUENCE OF WHITE MATTER HYPERINTENSITIES ON THE PREDICTIVE PERFORMANCE OF ALZHEIMER’S AND NEURODEGENERATION BIOMARKERS FOR COGNITIVE DECLINE IN NON-DEMENTED ADULTS

Shreyasee Das

Belgium

Abstract: PLASMA SNAP25 HAS DIAGNOSTIC AND PROGNOSTIC POTENTIAL IN PRE-CLINICAL ALZHEIMER’S DISEASE: A MULTI- COHORT STUDY

Hannah de Bruin

Germany

Abstract: CONNECTIVITY AS A UNIVERSAL PREDICTOR OF TAU SPREADING IN ATYPICAL ALZHEIMER’S DISEASE

Evangelos Galaris

Sweden

Abstract: IDENTIFYING SPATIAL PATTERNS OF WHITE MATTER HYPERINTENSITIES USING SPECTRAL CLUSTERING

Alexandra Gogola

United States

Abstract: TAU IMAGING THRESHOLDS AS PREDICTORS OF TAU ACCUMULATION AND COGNITIVE DECLINE IN NON-DEMENTED INDIVIDUALS IN THE NIA-AA MULTILEVEL TAU STAGING

Julia Greenland

United Kingdom

Abstract: AZATHIOPRINE FOR PARKINSON’S DISEASE: A RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (AZA-PD)

Nanna Møller Jensen

Denmark

Abstract: THE LRRK2-LEWY BODY CONUNDRUM: DEMONSTRATION OF WIDESPREAD ALPHA-SYNUCLEIN AGGREGATE PATHOLOGY IN LEWY BODY-NEGATIVE LRRK2-MUTANT CASES

Charmaine Lim

Austria

Abstract: MODELLING PRODROMAL PARKINSON’S DISEASE: PROGRESSION OF ALPHA-SYNUCLEINOPATHY FROM HUMAN-DERIVED LEWY BODY INOCULATIONS IN THE MOUSE OLFACTORY BULB

Arthur Macedo

Canada

Abstract: THE SPATIAL SPREAD OF TAUOPATHY PRECEDES THE INCREASE IN TAU-PET SUVR IN ALZHEIMER’S DISEASE

Johannes Michaelian

Australia

Abstract: FRAILTY, SARCOPENIA, BLOOD-BASED BIOMARKERS OF NEURODEGENERATION AND INCIDENT DEMENTIA: A 17-YEAR LONGITUDINAL POPULATION STUDY

Milan Nemy

Sweden

Abstract: VALIDATION OF CHOLINERGIC WHITE MATTER BIOMARKERS IN ALZHEIMER’S DISEASE AND DEMENTIA WITH LEWY BODIES

Maria Tzousi Papavergi

The Netherlands

Abstract: DECIPHERING THE ROLE OF COMPLEMENT C3 IN ANTI-AMYLOID ANTIBODY-INDUCED ARIA

Carmen Peña Bautista

Sweden

Abstract: PLASMA AND MRI BIOMARKERS IN DEMENTIA WITH LEWY BODIES AND ALZHEIMER’S DISEASE

Sherilyn Junelle Recinto

Canada

Abstract: UNVEILING PINK1-MEDIATED REGULATION OF MTDNA-DEPENDENT CGAS/STING-NF-KB SIGNALING IN MYELOID CELLS FOR THERAPEUTICALLY TARGETING THE INITIATING MECHANISMS OF PARKINSON’S DISEASE

Sebastian N. Roemer-Cassiano

Germany

Abstract: AMYLOID-ASSOCIATED HYPERCONNECTIVITY DRIVES TAU SPREADING ACROSS CONNECTED BRAIN REGIONS IN ALZHEIMER’S DISEASE

Susan Rohde

Netherlands

Abstract: HIPPOCAMPAL AMYLOID-BETA AND TAU DISTRIBUTIONS DIFFERENTIALLY AFFECT COGNITION IN CENTENARIANS

Hayley Shanks

Canada

Abstract: CHOLINERGIC BASAL FOREBRAIN DEGENERATION PREDICTS INDIVIDUALIZED TRAJECTORIES OF CORTICAL TAU PATHOLOGY AND COGNITIVE DECLINE

Sho Shimohama

Japan

Abstract: THE ICELANDIC MUTATION (APP-A673T) IS PROTECTIVE AGAINST AMYLOID PATHOLOGY IN VIVO

Lynn van Olst

United States

Abstract: ASPATIAL TRANSCRIPTOMICS REVEALS MICROGLIAL MECHANISMS OF AMYLOID-BETA CLEARANCE IN IMMUNIZED ALZHEIMER’S DISEASE PATIENTS